Published in J Gastroenterol Hepatol on August 01, 2013
Non-alcoholic fatty liver disease: what the clinician needs to know. World J Gastroenterol (2014) 1.02
Immune dysfunction in cirrhosis. World J Gastroenterol (2014) 1.02
Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol (2014) 0.97
Impaired balance of T helper 17/T regulatory cells in carbon tetrachloride-induced liver fibrosis in mice. World J Gastroenterol (2014) 0.86
Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice. PLoS One (2015) 0.85
Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease. J Nutr Biochem (2015) 0.81
IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression. Curr Drug Targets (2015) 0.78
Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response. Int J Inflam (2015) 0.77
Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease? World J Gastroenterol (2016) 0.76
Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice. Sci Rep (2016) 0.75
CD4(+) T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients. World J Hepatol (2017) 0.75
The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci U S A (2010) 3.18
Liver: An organ with predominant innate immunity. Hepatology (2008) 3.13
Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab (2010) 2.89
Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology (2009) 1.61
Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem (2003) 1.45
Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res (2011) 1.35
Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. Am J Physiol Gastrointest Liver Physiol (2007) 1.34
STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice. Hepatology (2006) 1.19
Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma. J Biol Chem (2010) 1.14
Retinoic acids and hepatic stellate cells in liver disease. J Gastroenterol Hepatol (2012) 1.05
CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice. Hepatology (2012) 1.01
Alterations of mast cells and TGF-beta1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis. World J Gastroenterol (2005) 0.94
Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice. J Hepatol (2012) 0.92
Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis. Expert Rev Gastroenterol Hepatol (2007) 0.91
Hepatic stellate cells and innate immunity in alcoholic liver disease. World J Gastroenterol (2011) 0.89
Alcohol dehydrogenase III exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice. Hepatology (2014) 0.87
Hepatic cannabinoid receptor type 1 mediates alcohol-induced regulation of bile acid enzyme genes expression via CREBH. PLoS One (2013) 0.86
Diagnostic evaluation of carbon tetrachloride-induced rat hepatic cirrhosis model. Anticancer Res (2005) 0.84
p53 and cell-cycle-regulated protein expression in small intestinal cells after fast-neutron irradiation in mice. Mol Cell Biochem (2005) 0.79
Retinoic acid-related orphan receptor alpha reprograms glucose metabolism in glutamine-deficient hepatoma cells. Hepatology (2015) 0.78
The protective effect of ENA Actimineral resource A on CCl4-induced liver injury in rats. Mar Biotechnol (NY) (2010) 0.78
Involvement of hepatic innate immunity in alcoholic liver disease. Immune Netw (2010) 0.78
Heavy water labeling method for measuring the effect of genistein on mammary gland carcinogenesis. Mol Cell Biochem (2007) 0.77
Primary hepatocyte imaging by multiphoton luminescent graphene quantum dots. Chem Commun (Camb) (2015) 0.77
ENA Actimineral Resource A restores bone loss and bone quality in ovariectomized rats. Mol Cell Biochem (2006) 0.75
Up-regulation of Metabotropic glutamate receptor 3 (mGluR3) in rat fibrosis and cirrhosis model of persistent hypoxic condition. Mol Cell Biochem (2006) 0.75
Proteome analysis by bio-active ceramic water in rat liver: contribution to antioxidant enzyme expression, SOD I. Biochem Biophys Res Commun (2004) 0.75
Protective effects of bio-active ceramic water on alcohol-induced hepatic injury in pigs. J Vet Med Sci (2005) 0.75
Effects of bio-active ceramic resources in cutaneous wound healing and the role of TGF-beta signaling. Mol Cell Biochem (2006) 0.75
Cytotoxic effects of the conjugated linoleic acid isomers t10c12, c9t11-CLA and mixed form on rat hepatic stellate cells and CCl4-induced hepatic fibrosis. J Nutr Biochem (2007) 0.75